David S. Sinasac

ORCID: 0000-0002-3749-5989
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metabolism and Genetic Disorders
  • Mitochondrial Function and Pathology
  • Diet and metabolism studies
  • ATP Synthase and ATPases Research
  • Genetic Mapping and Diversity in Plants and Animals
  • Neonatal Health and Biochemistry
  • Amino Acid Enzymes and Metabolism
  • Pancreatic function and diabetes
  • Genetic and phenotypic traits in livestock
  • Genetic Neurodegenerative Diseases
  • Folate and B Vitamins Research
  • Lysosomal Storage Disorders Research
  • Diet, Metabolism, and Disease
  • Liver Disease Diagnosis and Treatment
  • RNA modifications and cancer
  • Adipose Tissue and Metabolism
  • Endoplasmic Reticulum Stress and Disease
  • Infant Nutrition and Health
  • Adenosine and Purinergic Signaling
  • Adipokines, Inflammation, and Metabolic Diseases
  • Hemoglobinopathies and Related Disorders
  • Cardiomyopathy and Myosin Studies
  • Lipid metabolism and biosynthesis
  • Genetics and Neurodevelopmental Disorders
  • Nutrition, Genetics, and Disease

University of Calgary
2012-2025

Alberta Children's Hospital
2011-2025

Calgary Laboratory Services
2021

University of Alberta
2019

Case Western Reserve University
2006-2015

University School
2015

Alberta Children's Hospital Research Institute
2012

Hospital for Sick Children
1999-2005

University of Toronto
1999-2003

The genetic architecture of complex traits underlying physiology and disease in most organisms remains elusive. We still know little about the number genes that underlie these traits, magnitude their effects, or extent to which they interact. Chromosome substitution strains (CSSs) enable statistically powerful studies based on testing engineered inbred have single, unique, nonoverlapping differences, thereby providing measures phenotypic effects are attributable individual chromosomes. Here,...

10.1073/pnas.0810388105 article EN Proceedings of the National Academy of Sciences 2008-12-10

Exome sequencing of two sisters with congenital cataracts, short stature, and white matter changes identified compound heterozygous variants in the PISD gene, encoding phosphatidylserine decarboxylase enzyme that converts to phosphatidylethanolamine (PE) inner mitochondrial membrane (IMM). Decreased conversion PE patient fibroblasts is consistent impaired (PISD) activity. Meanwhile, as evidence for dysfunction, exhibited more fragmented networks, enlarged lysosomes, decreased maximal oxygen...

10.26508/lsa.201900353 article EN cc-by Life Science Alliance 2019-03-11

The CCAAT/enhancer-binding protein beta (C/EBPbeta) is required for adipocyte differentiation and maturation. We have studied the role of transcription factor, C/EBPbeta, in development diet-induced obesity. Mice with a deletion gene C/EBPbeta (C/EBPbeta(-/-)) wild-type mice were fed high-fat diet (60% fat) 12 weeks. C/EBPbeta(-/-) lost body fat, whereas increased their total fat on diet. had lower levels blood triglycerides, free fatty acids, cholesterol, hepatic triglyceride accumulation...

10.2337/db06-0310 article EN Diabetes 2006-12-27

The dilated cardiomyopathy with ataxia (DCMA) syndrome is a rare mitochondrial disorder caused by mutations in the poorly understood DNAJC19 gene. Cardiac involvement DCMA ranges from mild conduction abnormalities to early severe myocardial dysfunction. Although evidence suggests that linked function, molecular underpinnings of this condition are unclear, and there no way predict which patients will develop life-threatening disease. To address this, we developed metabolic flux assay for...

10.1002/jimd.70018 article EN cc-by-nc-nd Journal of Inherited Metabolic Disease 2025-03-01

Citrin is the liver-type mitochondrial aspartate-glutamate carrier that participates in urea, protein, and nucleotide biosynthetic pathways by supplying aspartate from mitochondria to cytosol. also plays a role transporting cytosolic NADH reducing equivalents into as component of malate-aspartate shuttle. In humans, loss-of-function mutations SLC25A13 gene encoding citrin cause both adult-onset type II citrullinemia neonatal intrahepatic cholestasis, collectively referred human deficiency....

10.1074/jbc.m702031200 article EN cc-by Journal of Biological Chemistry 2007-06-26

Summary Objective The ketogenic diet (KD) is a proven treatment for drug‐resistant (DR) seizures in children and adolescents. However, the relationship between seizure control most commonly measured metabolite of diet, ketone body d ‐beta‐hydroxybutyrate (D‐BHB), controversial. This study was performed to clarify because specific bodies may be useful as biomarkers efficacy. Methods Families with DR were approached participation this open‐label, prospective when they referred KD at two...

10.1002/epi4.12058 article EN cc-by-nc-nd Epilepsia Open 2017-04-07

Adult-onset type II citrullinemia (CTLN2) is an autosomal recessive disease caused by mutations in SLC25A13, the gene encoding mitochondrial aspartate/glutamate carrier citrin. The absence of citrin leads to a liver-specific, quantitative decrease argininosuccinate synthetase (ASS), causing hyperammonemia and citrullinemia. To investigate physiological role development CTLN2, Slc25a13-knockout (also known as Ctrn-deficient) mouse model was created. resulting Ctrn-/- mice were devoid Slc25a13...

10.1128/mcb.24.2.527-536.2004 article EN Molecular and Cellular Biology 2003-12-31

We used patient dermal fibroblasts to characterize the mitochondrial abnormalities associated with dilated cardiomyopathy ataxia syndrome (DCMA) and study effect of mitochondrially-targeted peptide SS-31 as a potential novel therapeutic. DCMA is rare understudied autosomal recessive disorder thought be related Barth but caused by mutations in DNAJC19, protein unknown function localized mitochondria. The clinical disease characterized 3-methylglutaconic aciduria, cardiomyopathy, abnormal...

10.3389/fcvm.2019.00167 article EN cc-by Frontiers in Cardiovascular Medicine 2019-11-15

Mutations in FBXL4 (F-Box and Leucine rich repeat protein 4), a nuclear-encoded mitochondrial with an unknown function, cause DNA depletion syndrome. We report two siblings, from consanguineous parents, harbouring previously uncharacterized homozygous variant (c.1750 T > C; p.Cys584Arg). Both patients presented encephalomyopathy, lactic acidosis cardiac hypertrophy, which are reported features of impairment. Remarkably, dichloroacetate (DCA) administration to the younger sibling improved...

10.1016/j.bbadis.2019.165536 article EN cc-by Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019-08-20

Genetic variation in the human population is a key determinant of influenza disease severity. A single nucleotide polymorphism antiviral gene IFITM3 was linked to outcomes during 2009 H1N1 pandemic. To identify variant host genes associated with increased virus replication and severe disease, we performed quantitative trait locus analysis on pro-inflammatory cytokine production 48 hours after intranasal infection highly pathogenic H5N1 virus. Pro-inflammatory cytokines CCL2, TNFα IFN-α, were...

10.1186/1471-2164-15-1017 article EN cc-by BMC Genomics 2014-01-01

Congenital disorders of glycosylation (CDG) are a group metabolic diseases resulting from defects in glycan synthesis or processing. The number subgroups and their phenotypic spectrums continue to expand with most related deficiencies N-glycosylation. ALG9-CDG (previously CDG-IL) is the result mutation ALG9. This gene encodes enzyme alpha-1,2-mannosyltransferase. To date, total 10 patients 6 different families have been reported one four ALG9 mutations. Seven these had similar phenotype...

10.1016/j.ymgmr.2017.08.004 article EN cc-by-nc-nd Molecular Genetics and Metabolism Reports 2017-09-07

We report on a 5-year-old female born to consanguineous parents, ascertained at the age of 23 months for an elevated plasma methionine level, mildly abnormal total homocysteine (tHcy), and aminotransferases. She had global developmental delay, microcephaly, dysmorphic facial features, hypotonia, nystagmus tremor in her upper extremities. Metabolic investigations demonstrated elevations methionine, S-adenosylmethionine (SAM) S-adenosylhomocysteine (SAH), with normal urine adenosine levels....

10.1002/jmd2.12064 article EN cc-by JIMD Reports 2019-07-22
Coming Soon ...